We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-14.3%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$85.3B
AUM Growth
-$21.5B
Cap. Flow
-$8.24B
Cap. Flow %
-9.67%
Top 10 Hldgs %
8.52%
Holding
6,080
New
596
Increased
1,780
Reduced
1,836
Closed
791

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Financials 10.31%
3 Healthcare 7.77%
4 Consumer Discretionary 7.11%
5 Industrials 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.A
4451
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$157K ﹤0.01%
+16,877
New +$206K
SNCE
4452
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$157K ﹤0.01%
3,900
PLXP
4453
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$157K ﹤0.01%
64,556
-47,069
-42% -$131K
ONEM
4454
CALL
DELISTED
1Life Healthcare
ONEM
$157K ﹤0.01%
20,000
OSUR icon
4455
OraSure Technologies
OSUR
$273M
$156K ﹤0.01%
+57,715
New +$287K
SAMAW
4456
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$156K ﹤0.01%
742,500
FCUV icon
4457
Focus Universal
FCUV
$1.6M
$155K ﹤0.01%
+51
New +$174K
VRM icon
4458
CALL
Vroom Inc
VRM
$37.5M
$155K ﹤0.01%
1,546
-5,000
-76% -$628K
BZH icon
4459
Beazer Homes USA
BZH
$903M
$154K ﹤0.01%
12,729
-19,809
-61% -$290K
ISD
4460
PGIM High Yield Bond Fund
ISD
$418M
$154K ﹤0.01%
12,500
LFST icon
4461
Lifestance Health
LFST
$4.15B
$154K ﹤0.01%
27,787
-120,854
-81% -$926K
BZUN
4462
CALL
Baozun
BZUN
$164M
$153K ﹤0.01%
14,000
-75,100
-84% -$660K
NMFC icon
4463
New Mountain Finance
NMFC
$649M
$153K ﹤0.01%
12,852
-15,068
-54% -$194K
SOND
4464
DELISTED
Sonder
SOND
$153K ﹤0.01%
+7,356
New +$418K
SMWB icon
4465
Similarweb
SMWB
$598M
$152K ﹤0.01%
+18,435
New +$194K
LVOX
4466
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$152K ﹤0.01%
91,402
+51,055
+127% +$126K
CRBU icon
4467
Caribou Biosciences
CRBU
$158M
$151K ﹤0.01%
27,884
-200,143
-88% -$1.53M
GORV
4468
DELISTED
Lazydays
GORV
$151K ﹤0.01%
+428
New +$218K
RYTM icon
4469
Rhythm Pharmaceuticals
RYTM
$7.28B
$151K ﹤0.01%
36,492
-60,493
-62% -$331K
SST.WS
4470
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$151K ﹤0.01%
186,079
-13,787
-7% -$27.4K
DSKE
4471
DELISTED
Daseke, Inc. Common Stock
DSKE
$151K ﹤0.01%
23,567
+2,782
+13% +$21.3K
CMAX
4472
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$151K ﹤0.01%
+1,391
New +$238K
SRTS icon
4473
Sensus Healthcare
SRTS
$49.7M
$150K ﹤0.01%
+19,595
New +$164K
NEUE
4474
DELISTED
NeueHealth
NEUE
$150K ﹤0.01%
1,033
-19,324
-95% -$2.81M
SAGAR
4475
DELISTED
Sagaliam Acquisition Corp. Rights
SAGAR
$150K ﹤0.01%
990,000
+495,000
+100% +$85.3K

Similar funds

D.E. Shaw & Co's Q2 2022 Portfolio in Review

As of Q2 2022, D.E. Shaw & Co held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

D.E. Shaw & Co withdrew a net $8.24B in Q2 2022, closing 791 positions and reducing 1,836 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in iShares MSCI Emerging Markets ETF worth $171M.

  • D.E. Shaw & Co's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
  • D.E. Shaw & Co added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
  • D.E. Shaw & Co's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
  • D.E. Shaw & Co fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
  • D.E. Shaw & Co's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
  • D.E. Shaw & Co opened 596 new positions and closed 791 in Q2 2022.
  • D.E. Shaw & Co's portfolio value fell 20% quarter-over-quarter to $85.3B.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.